Skip to content

Avenir Management Company, LLC

Follow

13F filer, CIK 1866419, NEW YORK, NY

Avenir Management Company, LLC reported $37,236,729 across 4 holdings for the quarter ended 2023-06-30, in a 13F-HR filed 2023-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001405086-23-000201

Period
2023-06-30
Reported value
$37.2M
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FINCH THERAPEUTICS GROUP INCreduced-1,607,921-$13.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2023

Share positions as resolved from 13F-HR 0001405086-23-000201, largest first. % of portfolio is the value over $37,236,729, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LTCHLATCH INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: 21,435,551 shares; 2022Q1: 21,435,551 shares; 2022Q2: 21,435,551 shares; 2022Q3: 21,435,551 shares; 2022Q4: 21,435,551 shares; 2023Q1: 21,435,551 shares; 2023Q2: 21,435,551 shares 21,435,551$29.8M80.02%0Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: not reported; 2022Q1: 24,199 shares; 2022Q2: 201,180 shares; 2022Q3: 201,180 shares; 2022Q4: 201,180 shares; 2023Q1: 201,180 shares; 2023Q2: 201,180 shares 201,180$5.21M14%0Timeline
UBERUBER TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: 183,312 shares; 2022Q1: 183,312 shares; 2022Q2: 183,312 shares; 2022Q3: 183,312 shares; 2022Q4: 183,312 shares; 2023Q1: 40,625 shares; 2023Q2: 40,625 shares 40,625$1.75M4.71%0Timeline
FINCH THERAPEUTICS GROUP INCFINCH THERAPEUTICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: 1,663,366 shares; 2022Q1: 1,663,366 shares; 2022Q2: 1,663,366 shares; 2022Q3: 1,663,366 shares; 2022Q4: 1,663,366 shares; 2023Q1: 1,663,366 shares; 2023Q2: 55,445 shares 55,445$473K1.27%-1,607,921

How Q2 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001405086-23-000201 base2023-08-14acceptance time not in the bulk data set